美股市場個股詳情
SANA Sana Biotechnology
- 1.650
- +0.050+3.13%
收盤價 12/20 16:00 (美東)
- 1.720
- +0.070+4.24%
盤後 18:59 (美東)
3.68億總市值-1.18市盈率TTM
1.720最高價1.550最低價320.19萬股成交量1.590今開1.600昨收528.22萬成交額2.45%換手率虧損市盈率(靜)2.23億總股本12.00052周最高1.26市淨率2.16億流通值1.55052周最低--股息TTM1.31億流通股44.600歷史最高--股息率TTM10.63%振幅1.550歷史最低1.649平均價1股每手
關於Sana Biotechnology公司
Sana Biotechnology Inc是一家生物技術公司。該公司開發工程細胞作爲治療疾病的藥物和療法。該公司致力於開發細胞工程項目，用於治療需求未得到滿足的廣泛治療領域，包括腫瘤學、糖尿病、B細胞介導的自身免疫和中樞神經系統（CNS）疾病等。其候選產品線包括SC291、SC262、SC255、UP421等。
公司介紹
公司代碼SANA
公司名稱Sana Biotechnology
上市日期2021/02/04
發行價格25.00
成立日期2018
CEODr. Steven D. Harr, M.D.
所屬市場納斯達克
員工數量328
年結日12-31
公司地址188 East Blaine Street,Suite 400
城市Seattle
省份華盛頓州
國家美國
郵編98102
電話1-206-701-7914
董事高管
- 姓名
- 職務
- 年薪
- Dr. Steven D. Harr, M.D.
- President, Acting Principal Financial Officer, Chief Executive Officer and Director
- 267.17萬
- Christian Hordo
- Executive Vice President and Chief Business Officer
- --
- Susan Wyrick
- Acting Chief Financial Officer, Acting Treasurer, and Acting Principal Accounting Officer
- --
- Bernard J. Cassidy
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Dr. Richard C. Mulligan, PhD
- Executive Vice Chairman of the Board
- --
- Hans Edgar Bishop
- Chairman of the Board
- 35.48萬
- Dr. Patrick Y. Yang, PhD
- Independent Director
- 29.98萬
- Dr. Alise S. Reicin, M.D.
- Independent Director
- 30.23萬
- Michelle Seitz, C.F.A.
- Independent Director
- 31.48萬
- Robert Taylor Nelsen
- Independent Director
- 29.48萬
- Dr. Joshua H. Bilenker, M.D.
- Independent Director
- 29.98萬
- Mary Agnes Wilderotter
- Independent Director
- 31.48萬
- Dr. Douglas G. Cole, M.D.
- Independent Director
- 30.23萬
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據